Overview

PET Tau - Neurodegenerative Disease Imaging

Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure the amount of a protein in the brain known as tau using an imaging procedure called Positron Emission Tomography (PET/CT). Tau has been shown to build up in the brains of patients with injury to brain cells. This study looks at neurodegenerative diseases such as frontotemporal degeneration (FTD).
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Pennsylvania
Collaborator:
Avid Radiopharmaceuticals